- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/062 - Dipeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
Patent holdings for IPC class C07K 5/062
Total number of patents in this class: 878
10-year publication summary
|
76
|
75
|
78
|
73
|
52
|
65
|
40
|
54
|
59
|
56
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biohaven Therapeutics Ltd. | 110 |
14 |
| Bristol-myers Squibb Company | 4820 |
12 |
| Albireo AB | 174 |
12 |
| Dana-Farber Cancer Institute, Inc. | 2623 |
12 |
| Nissan Chemical Industries, Ltd. | 1698 |
11 |
| Allergan, Inc. | 2314 |
10 |
| Cornell University | 3358 |
9 |
| MedImmune Limited | 630 |
9 |
| Arvinas Operations, Inc. | 244 |
9 |
| Case Western Reserve University | 1846 |
8 |
| ImmunoGen, Inc. | 403 |
8 |
| Hoffmann-La Roche Inc. | 3533 |
7 |
| Siemens Medical Solutions USA, Inc. | 1498 |
7 |
| Helsinn Healthcare SA | 229 |
7 |
| Medivir AB | 119 |
7 |
| On Target Laboratories, LLC | 32 |
7 |
| Ono Pharmaceutical Co., Ltd. | 428 |
7 |
| The University of Tokyo | 4249 |
7 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 311 |
7 |
| Evonik Operations GmbH | 4172 |
7 |
| Other owners | 701 |